224 related articles for article (PubMed ID: 28766409)
1. Phase 1 healthy volunteer willingness to participate and enrollment preferences.
Chen SC; Sinaii N; Bedarida G; Gregorio MA; Emanuel E; Grady C
Clin Trials; 2017 Oct; 14(5):537-546. PubMed ID: 28766409
[TBL] [Abstract][Full Text] [Related]
2. Motivations, enrollment decisions, and socio-demographic characteristics of healthy volunteers in phase 1 research.
Grady C; Bedarida G; Sinaii N; Gregorio MA; Emanuel EJ
Clin Trials; 2017 Oct; 14(5):526-536. PubMed ID: 28783972
[TBL] [Abstract][Full Text] [Related]
3. Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study.
Fisher JA; McManus L; Cottingham MD; Kalbaugh JM; Wood MM; Monahan T; Walker RL
PLoS Med; 2018 Nov; 15(11):e1002698. PubMed ID: 30457992
[TBL] [Abstract][Full Text] [Related]
4. The motivations, barriers, and sociodemographic characteristics of healthy Chinese volunteers in phase I research.
Wang Z; Chen G; Liu X; Liu C; Song Q; Wang J
Eur J Clin Pharmacol; 2021 Apr; 77(4):557-568. PubMed ID: 33188452
[TBL] [Abstract][Full Text] [Related]
5. Picking and Choosing Among Phase I Trials : A Qualitative Examination of How Healthy Volunteers Understand Study Risks.
Fisher JA; Monahan T; Walker RL
J Bioeth Inq; 2019 Dec; 16(4):535-549. PubMed ID: 31713712
[TBL] [Abstract][Full Text] [Related]
6. Why healthy subjects volunteer for phase I studies and how they perceive their participation?
Almeida L; Azevedo B; Nunes T; Vaz-da-Silva M; Soares-da-Silva P
Eur J Clin Pharmacol; 2007 Nov; 63(11):1085-94. PubMed ID: 17891536
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial compensation: How much do healthy volunteers actually earn from clinical trial enrollment?
Fisher JA; McManus L; Kalbaugh JM; Walker RL
Clin Trials; 2021 Aug; 18(4):477-487. PubMed ID: 33938244
[TBL] [Abstract][Full Text] [Related]
8. To report or not to report: Exploring healthy volunteers' rationales for disclosing adverse events in Phase I drug trials.
McManus L; Fisher JA
AJOB Empir Bioeth; 2018; 9(2):82-90. PubMed ID: 29693508
[TBL] [Abstract][Full Text] [Related]
9. Comprehension and recall from the informed consent process by phase I healthy volunteers before dose administration.
Tadros R; Caughey GE; Johns S; Shakib S
Clin Trials; 2019 Jun; 16(3):283-289. PubMed ID: 30818994
[TBL] [Abstract][Full Text] [Related]
10. Healthy participants in phase I clinical trials: the quality of their decision to take part.
Rabin C; Tabak N
J Clin Nurs; 2006 Aug; 15(8):971-9. PubMed ID: 16879541
[TBL] [Abstract][Full Text] [Related]
11. How important is 'accuracy' of surrogate decision-making for research participation?
Kim SY; Kim HM; Ryan KA; Appelbaum PS; Knopman DS; Damschroder L; De Vries R
PLoS One; 2013; 8(1):e54790. PubMed ID: 23382969
[TBL] [Abstract][Full Text] [Related]
12. Understanding preferences regarding consent for pragmatic trials in acute care.
Dickert NW; Wendler D; Devireddy CM; Goldkind SF; Ko YA; Speight CD; Kim SY
Clin Trials; 2018 Dec; 15(6):567-578. PubMed ID: 30280582
[TBL] [Abstract][Full Text] [Related]
13. A Study on the Characteristics of Healthy Volunteers who Participate in Phase I Clinical Trials in Korea.
Seo JH; Kim OJ; Yoo SH; Choi EK; Park JE
J Empir Res Hum Res Ethics; 2022; 17(1-2):193-212. PubMed ID: 34414819
[TBL] [Abstract][Full Text] [Related]
14. Impact of gender on the decision to participate in a clinical trial: a cross-sectional study.
Lobato L; Bethony JM; Pereira FB; Grahek SL; Diemert D; Gazzinelli MF
BMC Public Health; 2014 Nov; 14():1156. PubMed ID: 25377601
[TBL] [Abstract][Full Text] [Related]
15. Using "clinical trial diaries" to track patterns of participation for serial healthy volunteers in U.S. phase I studies.
Edelblute HB; Fisher JA
J Empir Res Hum Res Ethics; 2015 Feb; 10(1):65-75. PubMed ID: 25742668
[TBL] [Abstract][Full Text] [Related]
16. Defining reasonable patient standard and preference for shared decision making among patients undergoing anaesthesia in Singapore.
Yek JL; Lee AK; Tan JA; Lin GY; Thamotharampillai T; Abdullah HR
BMC Med Ethics; 2017 Feb; 18(1):6. PubMed ID: 28148256
[TBL] [Abstract][Full Text] [Related]
17. Who is willing to participate in low-risk pragmatic clinical trials without consent?
Dal-Ré R; Carcas AJ; Carné X
Eur J Clin Pharmacol; 2017 Dec; 73(12):1557-1563. PubMed ID: 28900674
[TBL] [Abstract][Full Text] [Related]
18. Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.
Cattapan A; Browne K; Halperin DM; Di Castri A; Fullsack P; Graham J; Langley JM; Taylor BA; McNeil SA; Halperin SA
Vaccine; 2019 Jan; 37(2):289-295. PubMed ID: 30528592
[TBL] [Abstract][Full Text] [Related]
19. Healthy individuals' perspectives on clinical research protocols and influences on enrollment decisions.
Roberts LW; Kim JP
AJOB Empir Bioeth; 2017; 8(2):89-98. PubMed ID: 28949845
[TBL] [Abstract][Full Text] [Related]
20. Healthy Volunteers' Perceptions of the Benefits of Their Participation in Phase I Clinical Trials.
Fisher JA; McManus L; Wood MM; Cottingham MD; Kalbaugh JM; Monahan T; Walker RL
J Empir Res Hum Res Ethics; 2018 Dec; 13(5):494-510. PubMed ID: 30296882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
